Manhattan Institute for Policy Research.
search  
 
Subscribe   Subscribe   MI on Facebook Find us on Twitter Find us on Instagram      
 
 
   
 
     
 
CITY JOURNAL
MI BOOKS
 
PUBLICATIONS
TOPICAL INDEX:
MI Publications &
City Journal Articles:
CENTER FOR STATE AND LOCAL LEADERSHIP:
Civic Reports
Urban Innovator Award
ARCHIVE:
Civic Bulletins (1994 to 2008)
Education Working Papers (2003 to 2006)
Fiscal Watch Memos (2002 to 2007)
The Jeremiah Project Reports & Lectures (1998)
CRRUCS Reports (2000 to 2003)
State of Religion Lectures (2001 to 2002)
The Council on Crime in America Reports (1996 to 1997)
CENTER FOR LEGAL POLICY:
Legal Policy Reports
Proxy Monitor Reports
Proxy Monitor Findings
Trial Lawyers Inc.
ARCHIVE:
Civil Justice Memos/Forums (1999 to 2007)
Global Liability Issues (2001 to 2002)
CENTER FOR MEDICAL PROGRESS:
Medical Progress Reports
Medical Progress Bulletins
Project FDA Reports
CENTER FOR ENERGY POLICY AND ENVIRONMENT:
Energy Policy & the Environment Reports
Power & Growth Initiative Reports
EMPIRE CENTER
Special Reports
MANHATTAN INSTITUTE:
Growth and Prosperity Reports
Issues 2012
President's Updates
Issue Briefs
William E. Simon Lectures
The Wriston Lectures
The Wilson Lectures
Hayek Prize
Testimony
Event Transcripts
ARCHIVE:
Manhattan Reports (1981 to 1987)
Manhattan Papers (1987 to 1989)
M.I. Conference Series (1999 to 2008)
M.I. Forums (1999 to 2002)
CENTER FOR RETHINKING DEVELOPMENT:
Rethinking Development Reports (2004 to 2009)
CRD Newsletters (2006 to 2009)
CENTER FOR POLICING TERRORISM:
Safe Cities Project Reports (2004 to 2006)
Policing Terrorism Reports (2007 to 2008)
CONTACT:
For general or media inquiries, please contact the Communications & Marketing Department, at communications@manhattan-institute.org or (212) 599-7000.
  MANHATTAN INSTITUTE PUBLICATIONS
Publications Type: Project FDA Report


An FDA Report Card: Wide Variance in Performance Found Among Agency's Drug Review
by Alexander Tabarrok, Joseph A. DiMasi, Christopher-Paul Milne
Project FDA Report 07, April 2014

The Digital Future of Molecular Medicine: Rethinking FDA Regulation
by Peter W. Huber
Project FDA Report 6, May 2013

Stifling New Cures: The True Cost of Lengthy Clinical Drug Trials
by Avik Roy
Project FDA Report 5, April 2012

Blue Pill or Red Pill: The Limits of Comparative Effectiveness Research
by Tomas J. Philipson, Eric Sun
Project FDA Report 4, June 2011

How Conflict-of-Interest Rules Endanger Medical Progress and Cures
by Richard A. Epstein
Project FDA Report 3, October 2010

Cost of Caution: The Impact on Patients of Delayed Drug Approvals
by Tomas J. Philipson, Eric Sun
Project FDA Report 2, June 2010

In the Wake of Wyeth v. Levine: Making the Case for FDA Preemption and Administrative Compensation
by James R. Copland, Paul Howard
Project FDA Report 1, March 2009



 

 
 
 

The Manhattan Institute, a 501(c)(3), is a think tank whose mission is to develop and disseminate new ideas
that foster greater economic choice and individual responsibility.

Copyright © 2014 Manhattan Institute for Policy Research, Inc. All rights reserved.

52 Vanderbilt Avenue, New York, N.Y. 10017
phone (212) 599-7000 / fax (212) 599-3494